Perampanel + Perampanel

Pre-clinicalCompleted

1 views this week 0 watching💤 Quiet

Interest: 26/100

Hype Score

Development Stage

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Seizures

Conditions

Seizures

Trial Timeline

Jan 21, 2020 → Mar 31, 2023

NCT ID

NCT04202159

About Perampanel + Perampanel

Perampanel + Perampanel is a pre-clinical stage product being developed by Eisai for Seizures. The current trial status is completed. This product is registered under clinical trial identifier NCT04202159. Target conditions include Seizures.

What happened to similar drugs?

12 of 20 similar drugs in Seizures were approved

Approved (12) Terminated (5) Active (7)

✅Adjunctive Zonisamide + Replacement with ZonisamideEisaiApproved

✅PerampanelEisaiApproved

✅Eslicarbazepine acetate + Eslicarbazepine AcetateSumitomo PharmaApproved

✅OxcarbazepineNovartisApproved

✅PregabalinPfizerApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (8)

NCT ID	Phase	Status	Start	Completion	Indication
NCT04202159	Pre-clinical	Completed	Jan 21, 2020	Mar 31, 2023	Seizures
NCT03754582	Phase 2	Completed	Nov 27, 2018	Dec 10, 2019	Epilepsy
NCT03399734	Phase 1	Completed	Dec 18, 2017	Mar 9, 2018	Healthy Participants
NCT03376997	Phase 1	Completed	Nov 8, 2017	Feb 16, 2018	Healthy Participants
NCT02020486	Phase 1	Completed	Dec 1, 2013	Mar 1, 2014	Healthy
NCT01396577	Phase 1	Completed	Dec 1, 2010	Apr 1, 2011	Healthy
NCT01396590	Phase 1	Completed	Dec 1, 2010	Mar 1, 2011	Healthy
NCT01240187	Phase 1	Completed	Jun 1, 2010	Sep 1, 2010	Partial Onset Epilepsy

Competing Products

20 competing products in Seizures

See all competitors

Product	Company	Stage	Hype Score
E2007	Eisai	Phase 3	40
Perampanel	Eisai	Pre-clinical	26
perampanel + perampanel + perampanel + Placebo	Eisai	Phase 3	40
perampanel	Eisai	Phase 2	35
Perampanel	Eisai	Pre-clinical	26
Zonisamide + Placebo	Eisai	Phase 3	40
zonisamide	Eisai	Pre-clinical	26
E2007 (perampanel) + E2007 (perampanel) + Placebo	Eisai	Phase 3	40
Perampanel + Placebo	Eisai	Phase 3	40
E2007 (perampanel) + E2007 (perampanel) + Placebo	Eisai	Phase 3	40
Adjunctive Zonisamide + Replacement with Zonisamide	Eisai	Approved	43
Fycompa	Eisai	Pre-clinical	26
Zonisamide + Placebo	Eisai	Phase 3	40
Fycompa	Eisai	Pre-clinical	26
Rufinamide	Eisai	Phase 3	32
Eslicarbazepine Acetate tablets	Eisai	Pre-clinical	26
Perampanel	Eisai	Pre-clinical	26
Perampanel	Eisai	Pre-clinical	26
Perampanel	Eisai	Approved	43
Zonisamide tablets	Eisai	Pre-clinical	26